glp 1 hepatic steatosis Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Glucagon-like Peptide-1 Receptor Agonists (GLP-1

However, it is unrealistic to think that the skin will return to exactly the way it was before the stretch marks appeared, regardless of the treatment plan

Additional information Liang Tang and Weiwei Wang contributed equally to this work Additional file Additional file 1

J Dermatolog Treat 33(3):14281434 Faurschou A et al (2015) Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patientsa randomized placebo-controlled trial

Kaufmans fear is that both trials will fail because too many patients will suffer side effects and withdraw, and the drug will be forever lost to vast majority of long-COVID patients